• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Healthcare Law's Impact on Businesses Varies

Article

Companies specializing in driving down spending on health care, whether through electronic records, preventive care or consolidating services, are turning out to be the biggest winners from the 2010 health care law.

Investors, analysts and policymakers say any business that can help health care providers cut costs or keep patients from being readmitted to the hospital soon after an in-patient visit is attracting more customers and seeing more investment.

Read the full story: http://usat.ly/PZgqBu

Source: USA Today

Related Videos
James Simon, MD – Image credit: AJMC
Brooke Aggarwal, EdD – screenshot by AJMC
Hearn Jay Cho, MD, PhD
Susan Cantrell, CEO of AMCP
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Dr Brian Koffman
Related Content
The real-world data support the long-term value of mepolizumab as an add-on maintenance therapy in severe asthma. | gustavofrazao - stock.adobe.com

Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma

October 26th 2025
Article

The real-world data support the long-term value of mepolizumab as an add-on maintenance therapy in severe asthma.

Read More

The Evolution of AI Models in Mammography With Robert Nishikawa, PhD

The Evolution of AI Models in Mammography With Robert Nishikawa, PhD

October 23rd 2025
Podcast

AI-powered mammography is enhancing breast cancer screening and early detection through cutting-edge radiology insights.

Listen

Woman lying on couch having hot flash, fanning herself | Image credit: DimaBerlin – stock.adobe.com

Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies

October 25th 2025
Article

New data reinforce elinzanetant’s safety, efficacy, and ability to improve sleep disturbances in menopausal women, independent of vasomotor symptom relief.

Read More

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

October 14th 2025
Podcast

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Regina Castaneda, MD | Image credit: AJMC

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

October 25th 2025
Article

Preclinical data suggest a possible synergistic interaction between estrogen and GLP-1 signaling, explains Regina Castaneda, MD.

Read More

Those with moderately increased baseline levels of CD45 + C1q + CCR8+ cells had a markedly higher risk of disease progression than those with lower levels. | Crystal light - stock.adobe.com

New Immune Cell Marker Offers Clues to Kidney Disease Progression

October 25th 2025
Article

CD45 + C1q + CCR8+ cells were found to be a novel immune-cell subset associated with kidney disease severity and progression risk.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.